Barclays on U.S. Specialty Pharmaceuticals: Mylan Influencing Lipitor Landscape?

Go back to Barclays on U.S. Specialty Pharmaceuticals: Mylan Influencing Lipitor Landscape?
Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

Pfizer Inc. (NYSE: PFE) Delayed: 28.07 +0.28 (1.01%)
Previous Close $27.79    52 Week High $37.39 
Open $27.77    52 Week Low $28.25 
Day High $28.43    P/E 17.01 
Day Low $27.66    EPS $1.65 
Volume 37,094,598       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 37.34 +0.53 (1.44%)
Previous Close $36.81    52 Week High $66.55 
Open $36.79    52 Week Low $37.82 
Day High $37.75    P/E N/A 
Day Low $36.65    EPS $0.00 
Volume 4,300,152       

Watson Pharmaceuticals, Inc. (NYSE: WPI) Delayed: 85.73 --0 (-0%)
Previous Close $85.73    52 Week High $91.47 
Open $16.30    52 Week Low $57.16 
Day High $85.73    P/E 66.46 
Day Low $85.73    EPS $1.29 
Volume 3,625